MedTrace Logo

Effect of Eccentric Streching vs IASTM of Gastrocnemius and Soleus Muscles in Athletes With Ankle Sprain

NCT06241001 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2024-02-05

No results posted yet for this study

Summary

The primary objective within the current study is to compare the acute and chronic effects of eccentric training and IASTM on the dorsiflexion ROM. To reduce the risk of Achilles tendinopathy, stretching and eccentric (lengthening) exercises are postulated to improve ankle dorsiflexion. An eccentric exercise lengthens an active muscle while it is under load. Consequently, eccentric calf muscle exercises can also increase ankle dorsiflexion through an increase in calf muscle strength. For the above mentioned reasons, a combination of stretching exercises and eccentric (lengthening) exercises are suggested as preventive intervention to increase ankle dorsiflexion. The biggest goal of IASTM is to remove scar tissues and facilitate a return to normal function following soft tissue recovery. These Techniques, eccentric stretching and IASTM works towards bringing back the normal range of motion and strength, allowing individuals to regain mobility and return to their usual activities and we will find out the better option from these.

Conditions

  • Ankle Sprains

Interventions

OTHER

eccentric streching

The player will lift up one leg from starting position so he stands on his to-be-trained leg. For performing eccentric exercises of the gastrocnemius muscles, the player will lower his heel until he will feel a slight stretch, while keeping his knee extended

OTHER

IASTM

Specially designed tools are used to apply longitudinal pressure along muscle fibers, and treatment usually includes applying to more than the tissues in the isolated location of the pain

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Abdul Wasay Nafe, MS-SPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-22
Primary Completion
2024-03-15
Completion
2024-05-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06241001 on ClinicalTrials.gov